Still relying on antimicrobials and ZnO?
Tread on solid ground with the shigatoxin vaccination.
Single dose vaccination protecting into the finishing period: ● neutralizes the causative agent of Edema disease ● reduces the use of antimicrobials and ZnO ● increases piglet growth
shigatoxin.com
Single dose Shiga toxin protection
Ceva Santé Animale
www.ceva.com
contact@ceva.com 10 Avenue de la Ballastière 33500 Libourne - France Phone: +33 5 57 55 40 40 Fax: +33 5 57 55 41 10
Ecoporc SHIGA suspension for injection for pigs. Qualitative and quantitative composition: Each dose of 1 ml contains: Active substance: Genetically modified re combinant Stx2e antigen: ≥ 3.2 x 106 ELISA units. Adjuvant:
Aluminium (as hydroxide) max. 3.5 mg. Excipient: Thiomersal max. 0.115 mg. Indications for use: Active immunisation of piglets from the age of 4 days, to reduce the mortality and clinical signs of oEdema disease caused by Stx2e toxin produced by E. coli (STEC). Onset of immunity: 21 days after vaccination. Duration of immunity: 105 days after vaccination. Contraindications: Do not use in case of hypersensitivity to the active substance, to the adjuvant or to any of the excipients. Adverse reactions: Commonly very small local reactions such as mild swelling at the injection site (maximum of 5 mm) may be observed, but these reactions are transient and subside within a short time (up to seven days) without treatment. Clinical signs such as temporary mild behavioural disturbances can uncommonly be observed after application of Ecoporc SHIGA. Commonly a slight rise in body temperature (maximum of 1.7 °C) may occur after injection. But these reactions subside within a short time (maximum of two days) without treatment. Withdrawal period: Zero days. Under veterinary prescription only. Marketing Authorisation Holder: IDT Biologika GmbH, Am Pharmapark, 06861 Dessau-Rosslau, Germany.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44